{"id":"https://openalex.org/W1967029438","doi":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","title":"Long\u2010Term Hypnotic Efficacy and Safety of Triazolam and Flurazepam","display_name":"Long\u2010Term Hypnotic Efficacy and Safety of Triazolam and Flurazepam","publication_year":1978,"publication_date":"1978-05-06","ids":{"openalex":"https://openalex.org/W1967029438","doi":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","mag":"1967029438","pmid":"https://pubmed.ncbi.nlm.nih.gov/25288"},"language":"en","primary_location":{"id":"doi:10.1002/j.1552-4604.1978.tb02450.x","doi":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057087955","display_name":"Morton Leibowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"MORTON LEIBOWITZ","raw_affiliation_strings":["Department of Medicine, New York University Medical Center, New York, N.Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, New York University Medical Center, New York, N.Y","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014480795","display_name":"Abraham N. Sunshine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ABRAHAM SUNSHINE","raw_affiliation_strings":["Department of Medicine, New York University Medical Center, New York, N.Y"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, New York University Medical Center, New York, N.Y","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5057087955"],"corresponding_institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":5.144,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.96013216,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"18","issue":"5-6","first_page":"302","last_page":"309"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10234","display_name":"Obstructive Sleep Apnea Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":1.0},{"id":"https://openalex.org/keywords/flurazepam","display_name":"flurazepam","score":1.0},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.9089999794960022},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tolerance-pharmacology-and-immunology","display_name":"tolerance (pharmacology and immunology)","score":0.492000013589859},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8220000267028809},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.9449999928474426},{"id":"https://openalex.org/keywords/onset-of-action","display_name":"onset of action","score":0.7480000257492065},{"id":"https://openalex.org/keywords/insomnia-treatment","display_name":"insomnia treatment","score":0.30399999022483826}],"concepts":[{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.9788743257522583},{"id":"https://openalex.org/C2776156762","wikidata":"https://www.wikidata.org/wiki/Q418998","display_name":"Flurazepam","level":4,"score":0.9228618741035461},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.7302442193031311},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5844055414199829},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.49715402722358704},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.47635936737060547},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.24064964056015015},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1171644926071167},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005479","descriptor_name":"Flurazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005479","descriptor_name":"Flurazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005479","descriptor_name":"Flurazepam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007319","descriptor_name":"Sleep Initiation and Maintenance Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012890","descriptor_name":"Sleep","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1552-4604.1978.tb02450.x","doi":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1978.tb02450.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:25288","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25288","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W1978774989","https://openalex.org/W2119273810","https://openalex.org/W2187904326","https://openalex.org/W2314858779"],"related_works":["https://openalex.org/W2119273810","https://openalex.org/W2009221943","https://openalex.org/W2439168463","https://openalex.org/W2013099481","https://openalex.org/W2406373092","https://openalex.org/W2009090546","https://openalex.org/W2416104079","https://openalex.org/W2045912535","https://openalex.org/W2159905454","https://openalex.org/W2412650989"],"abstract_inverted_index":{"Both":[0],"triazolam":[1,21],"and":[2,51,90,103,119,128],"flurazepam":[3,99,116,143],"are":[4],"effective":[5],"hypnotics":[6],"when":[7],"administered":[8],"nightly":[9],"for":[10],"12":[11],"consecutive":[12],"weeks.":[13],"However,":[14],"at":[15],"the":[16,41,46,55,78,104,115,129,142],"dosages":[17],"tested,":[18],"0.6":[19],"mg":[20,31],"had":[22],"a":[23],"significantly":[24,112,139],"faster":[25],"onset":[26],"of":[27,35,106,131],"activity":[28],"than":[29,100],"30":[30],"flurazepam.":[32],"Long-term":[33],"administration":[34],"either":[36,64,73],"treatment":[37,74],"did":[38],"not":[39],"influence":[40],"patient's":[42],"capability":[43],"to":[44,72],"recognize":[45],"difference":[47],"between":[48],"active":[49],"drug":[50],"placebo.":[52],"This":[53],"supports":[54],"conclusion":[56],"that":[57],"there":[58],"was":[59,111,137],"no":[60,68],"tolerance":[61],"development":[62],"on":[63,98,101,125],"treatment.":[65],"There":[66],"were":[67,121],"deleterious":[69],"effects":[70,94,110],"attributable":[71],"as":[75],"measured":[76],"by":[77,84],"35-Item":[79],"Hopkins":[80],"Symptom":[81],"Checklist":[82],"or":[83,135],"physical":[85],"examinations,":[86],"laboratory":[87],"tests,":[88],"ECGs,":[89],"ophthalmologic":[91],"examinations.":[92],"Side":[93],"occurred":[95],"more":[96],"often":[97],"triazolam,":[102],"number":[105,130],"patients":[107,132],"experiencing":[108],"side":[109],"higher":[113,140],"in":[114,141],"group.":[117,144],"Drowsiness":[118],"grogginess":[120,136],"reported":[122],"most":[123],"frequently":[124],"both":[126],"treatments,":[127],"reporting":[133],"drowsiness":[134],"also":[138]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}